RESPONSE: Seladelpar Normalizes Alkaline Phosphatase, Reduces Pruritus in PBC

Results from the phase 3 trial showed seladelpar elicited biochemical response, normalized alkaline phosphatase, and reduced pruritus at a greater rate than placebo.

Related Keywords

Toronto ,Ontario ,Canada ,David Assis ,Terry Horner ,Gideon Hirschfield ,Yale School Of Medicine ,Autoimmune Liver Disease Research ,Drug Administration ,University Of Toronto ,Foundation Gideon Hirschfield ,New England Journal ,Yale School ,Cymabay Therapeutic New Drug Application ,Priority Review ,Prescription Drug User Fee Act ,Terry Horner Chair ,Primary Biliary ,Improves Markers ,Second Line Treatment ,Cpbc ,Primary Biliary Cholangitis ,Seladelpar ,Biochemical Response ,Alkaline Phosphatase ,Normalization ,Pruritus ,Ursodeoxycholic Acid ,Obeticholic Acid ,